Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdallah MH, Sabry SA, Hasan AA (2016) Enhancing transdermal delivery of glimepiride via entrapment in proniosomal gel. J Young Pharm 8(4):335–340
Abdelkader H, Farghaly U, Moharram H (2014) Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig 44(5):329–337
Ammar HO, Haider M, Ibrahim M, El Hoffy NM (2017) In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration. Drug Deliv 24(1):414–421
Asthana GS, Asthana A, Singh D, Parveen Kumar S (2016) Etodolac containing topical niosomal gel: formulation development and evaluation. J Drug Deliv 2016:8 (Article ID 9324567)
Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99(4):2049–2060
Bonomi L, Perfetti S, Noya E, Bellucci R, Iomazzolli I (1978) Experimental corticosteroid ocular hypertension in the rabbit. Albrecht Von Graefe’s Arch Klin Exp Ophthalmol 209(2):73–82
Dharashivkar SS, Sahasrabuddhe SH, Saoji AN (2014) Niosomally encapsulated silver sulfadiazine gel for burn treatment. J Microencapsul 32(2):137–142
Dubey A, Prabhu P (2014) Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma. Int J Pharm Investig 4:112–118
Dubey A, Prabhu P, Beladiya K, Nair N, Ghate V (2015) Development and investigation of timolol maleate and latanoprost combination liposomes for the treatment of glaucoma. Int Res J Pharm 6(4):256–264
El-Assal MIA (2017) Proniosomes as nano-carrier for transdermal delivery of atenolol niosomal gel. Int J Drug Deliv Technol 7(4):283–297
Elsaied EH, Dawaba HM, Ibrahim EA, Afouna MI (2016) Investigation of proniosomes gel as a promising carrier for transdermal delivery of glimepiride. Univ J Pharm Res 1(2):1–18
Erfani Jabarian L, Rouini MR, Atyabi F, Foroumadi A, Nassiri SM, Dinarvand R (2013) In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. Eur J Pharm Sci 48(1–2):87–96
Hiremath P, Shivanand S, Reddy JJ, Jamakandi VG (2018) Design and evaluation of transdermal patches of timolol maleate. Curr Drug Deliv 15(5):658–663
Huang J, Peng T, Li Y, Zhan Z, Zeng Y, Huang Y, Pan X, Wu c, Wu C (2017) Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. Am Assoc Pharm Sci 18(8):2919–2926
Ilkhanizadeh B, Mehrshad A, Seddighnia A, Zarei L (2017) Comparison between effects of free and niosomal formulations of Artemisia annua L. (Asteraceae) on chronic myelogenous leukemia (K562) cell line. Int J Pharmacol 13(2):191–197
Kaur V, Pawar P (2015) Formulation and evaluation of moxifloxacin hydrochloride niosomes for controlled ophthalmic drug delivery. J Pharm Technol Res Manag 3(1):11–28
Kurniawansyah IS, Rahmi F, Sopyan I (2018) pH triggered in-situ gelling ophthalmic drug delivery system. Int J Drug Deliv Technol 8(1):1–5
Mathure D, Madan R, Gujar JN, Tupsamundre K, Ranpise AA, Dua H K (2018) Formulation and evaluation of niosomal in situ nasal gel of a serotonin receptor agonist, buspirone hydrochloride for the brain delivery via intranasal route. Pharm Nanotechnol 6(1):69–78
Mavaddati MA, Moztarzadeh F, Baghbani F (2015) Effect of formulation and processing variables on dexamethasone entrapment and release of niosomes. J Cluster Sci 26(6):2065–2078
Morsi N, Ghorab D, Refai H, Teba H (2016) Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 506(1–2):57–67
Musa MN, David SR, Zulkipli IN, Mahadi AH, Chakravarthi S, Rajan Rajabalaya (2017) Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations. Bioimpacts; 7(4): 227–239
Muzzalupo R, Tavano L (2015) Niosomal drug delivery for transdermal targeting: recent advances. Res Rep Transdermal Drug Deliv 2015(4):23–33
Nair SC, Kumar BS, Krishna R, Lakshmi PS, Vasudev DT (2017) Formulation and evaluation of niosomal suspension of cefixime. Asian J Pharm Clin Res 10(5):194
Patel KK, Kumar P, Thakkar HP (2012) Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech 13(4):1502–1510
Pawar HA, Attarde VB, Parag Subhash G (2016) Optimization of bifonazole-loaded nisomal formulation using plackett-burman design and 2 factorial design. Open Pharm Sci J 3(1):31–48
Preethi GB, Kunal P (2016) Design and evaluation of controlled-release ocular inserts of brimonidine-tartrate and timolol maleate. Int J Pharm Pharm Sci 9(1):79
Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S (2018) Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics 10(1):26
Rahimpour Y, Hamishehkar H (2012) Niosomes as carrier in dermal drug delivery. Recent advances in novel drug carrier systems. Chap 6, pp 141–164. https://doi.org/10.5772/51729
Rasool BKA, Azeez OS, Lootah HA, Abusharbain IM, Abu-Alhaj HA, Nessa F (2014) Extended release niosomal hydrogel for ocular targeting of piroxicam: in vitro and ex vivo evaluation. Br J Pharm Res 4(21):2494–2510
Ravalika V, Sailaja AK (2017) Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method. Nano Biomed Eng 9(3):242–248
Raza K, Kumar M, Kumar P, Malik R, Sharma G, Kaur M, Katare OP (2014) Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems. BioMed Res Int 2014:1–11
Reimondez-Troitiño S, Csaba N, Alonso MJ, de la Fuente M (2015) Nanotherapies for the treatment of ocular diseases. Eur J Pharm Biopharm 95(Pt B):279–293
Sammour OA, Marzouk MA, Ramadan AA, Shawky SM (2013) In-vitro permeation and pharmaco-dynamic properties of gel formulations containing tenoxicam entrapped niosomes. J Life Med 1(1):1–10
Satish J, Jenelle J, Lexley PP, Amusa AS, Gopalakrishna P (2016) Acute and subacute toxicity of sorbitan monostearate (span 60) non-ionic surfactant vesicles (niosomes) in sprague dawley rats. Br J Pharm Res 14(2):1–9
Sawant D, Dandag PM, Gadad AP (2015) Formulation and evaluation of sparfloxacin emulsomes-loaded thermosensitive in situ gel for ophthalmic delivery. J Sol Gel Sci Technol 77(3):654–665
Sezgin-Bayindir Z, Antep MN, Yuksel N, Yuksel N (2015) Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug. AAPS PharmSciTech 16(1):108–117
Sharda Sambhakar S, Paliwal S, Sharma B, Singh (2017) Formulation of risperidone loaded proniosomes for effective transdermal delivery: an in-vitro and in-vivo study. Bull Fac Pharm Cairo Univ 55(2):239–247
Sreya M, Krishna Sailaja A (2017) Preparation and evaluation of diclofenac sodium niosomal formulations. J Bionanosci 11(6):489–496
Taymouri S, Varshosaz J (2016) Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res 5(1):48